Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: Relation to age and lymph node status

被引:32
作者
Collett, K
Hartveit, F
Skjaerven, R
Maehle, BO
机构
[1] UNIV BERGEN,HAUKELAND HOSP,GADE INST,DEPT PATHOL,N-5021 BERGEN,NORWAY
[2] UNIV BERGEN,HAUKELAND HOSP,GADE INST,MED INFORMAT & STAT SECT,N-5021 BERGEN,NORWAY
关键词
oestrogen receptor; progesterone receptor; breast cancer; prognosis;
D O I
10.1136/jcp.49.11.920
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To consider the prognostic role of oestrogen receptor and progesterone receptor status in relation to the age at surgery, length of follow up and lymph node status. Methods-The study population comprised 977 patients with histologically confirmed breast carcinoma, with a median follow up of nine years. The actuarial life table method was used to test for survival differences. The Cox proportional hazard model was used to test for interaction effects between each hormone receptor and age, lymph node status and length of follow up. As the analysis involved multiple subgroups, significance was set at the 1% level (p < 0.01). Results-When the patients were subdivided into groups according to lymph node status and age, progesterone and oestrogen receptor status predicted prognosis in middle aged (46-60 years) patients with lymph node positive breast cancer. Their prognostic effect in this subgroup, however, was restricted to the first five years after surgery. Progesterone receptor status was the strongest predictor of outcome. Conclusion-The prognostic power of oestrogen and progesterone receptor status varies depending on age, lymph node status and length of follow up after surgery.
引用
收藏
页码:920 / 925
页数:6
相关论文
共 33 条
[11]   ADJUVANT THERAPY OF BREAST-CANCER [J].
DAVIDSON, NE ;
ABELOFF, MD .
WORLD JOURNAL OF SURGERY, 1994, 18 (01) :112-116
[12]  
Dixon WJ, 1990, BMDP STAT SOFTWARE
[13]   THE NOTTINGHAM PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER [J].
GALEA, MH ;
BLAMEY, RW ;
ELSTON, CE ;
ELLIS, IO .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) :207-219
[14]  
Glick J H, 1993, Recent Results Cancer Res, V127, P289
[15]   THE EFFECT OF ESTROGEN AND PROGESTERONE RECEPTORS ON RECURRENCE AND SURVIVAL IN PATIENTS WITH CARCINOMA OF THE BREAST [J].
HOWAT, JMT ;
HARRIS, M ;
SWINDELL, R ;
BARNES, DM .
BRITISH JOURNAL OF CANCER, 1985, 51 (02) :263-270
[16]   THE PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR (EGF-R) IN PRIMARY BREAST-CANCER - RESULTS OF A 10-YEAR FOLLOW-UP-STUDY [J].
KLIJN, JGM ;
LOOK, MP ;
PORTENGEN, H ;
ALEXIEVAFIGUSCH, J ;
VANPUTTEN, WLJ ;
FOEKENS, JA .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (01) :73-83
[17]  
LOGAN LA, 1982, CAN J SURG, V25, P581
[18]   SEASON OF INITIAL DISCOVERY OF TUMOR AS AN INDEPENDENT VARIABLE PREDICTING SURVIVAL IN BREAST-CANCER [J].
MASON, BH ;
HOLDAWAY, IM ;
STEWART, AW ;
NEAVE, LM ;
KAY, RG .
BRITISH JOURNAL OF CANCER, 1990, 61 (01) :137-141
[19]   THE PROGNOSTIC VALUE OF ESTROGEN AND PROGESTERONE RECEPTORS IN FEMALE BREAST-CANCER - A SINGLE CENTER STUDY [J].
MATHIESEN, O ;
BONDERUP, O ;
CARL, J ;
PANDURO, J ;
PEDERSEN, KO .
ACTA ONCOLOGICA, 1991, 30 (06) :691-695
[20]  
McGuire W L, 1986, NCI Monogr, P19